US EditionPhilips Agrees to Acquire Spectrawave inc., Advancing Next-Generation Coronary Intravascular ...
Philips expands its coronary imaging portfolio by acquiring SpectraWAVE's AI-powered HyperVue and X1-FFR technologies, enhancing image-guided therapy for over 7.6 million patients annually.
- Royal Philips said it has agreed to acquire SpectraWAVE, Inc., adding HyperVue and X1‑FFR technologies to its coronary imaging portfolio.
- Philips said the acquisition expands its lineup by adding DeepOCT+NIRS imaging and angiography‑derived FFR to its existing IVUS and iFR offerings, accelerating intravascular imaging adoption.
- Regulatory filings show SpectraWAVE HyperVue Imaging System and X1‑FFR software hold U.S. Food and Drug Administration Class 2 clearances.
- The deal broadens Philips' intravascular toolkit with Eagle Eye Platinum digital IVUS and IntraSight, while financial terms were not disclosed and investors will watch effects on procedure volumes and Philips' 2026 outlook.
- This acquisition continues Philips' AI-driven image-guided therapy expansion, leveraging Azurion, which treats more than 7.6 million patients annually in over 80 countries.
17 Articles
17 Articles
Hastings Tribune
Enid News & EagleDecember 15, 2025
NiagaraFallsReview.ca
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI
December 15, 2025
Philips acquires U.S. AI firm SpectraWAVE to expand heart disease treatment technology
Philips has acquired U.S.-based company SpectraWAVE, which uses artificial intelligence (AI) to map and assess blood vessels, a move the Dutch healthcare technology firm says will enhance treatment for patients with coronary heart disease, including heart attacks.SpectraWAVE, founded in 2017 and based in Bedford, Massachusetts, employs more than seventy people. The financial terms of the acquisition have not been disclosed. Philips said the purc…
Philips Agrees to Acquire SpectraWave
December 15, 2025—Royal Philips announced it has entered into an agreement to acquire SpectraWave, Inc. Founded in 2017 and based in Bedford, Massachusetts, SpectraWave is a developer of technology for enhanced vascular imaging (EVI) of coronary arteries, angiography-based physiology assessments, and the use of artificial intelligence (AI) in medical imaging. Its intravascular imaging and physiologic assessment technologies provide solutions for…
Philips Acquires SpectraWAVE to “Double Down” on AI-Powered Coronary Imaging
What You Should Know: – Philips has agreed to acquire SpectraWAVE, Inc., a move designed to bolster its leadership in image-guided therapy by integrating SpectraWAVE’s AI-powered coronary imaging and physiology assessments into the Philips Azurion platform. – The acquisition adds critical next-generation capabilities, including DeepOCT (optical coherence tomography) and wire-free Fractional Flow Reserve (FFR), to Philips’ existing portfolio. –…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
